Affimed N.V. (NASDAQ:AFMD) declined after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019. Affimed N.V. (NASDAQ:AFMD), a Healthcare sector …
Tag: LOGC
Affimed N.V. (NASDAQ:AFMD) declined after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019. Affimed N.V. (NASDAQ:AFMD), a Healthcare sector …